2026 ICD-10-CM Diagnosis Code C81.76Other Hodgkin lymphoma, intrapelvic lymph nodes

ICD-10-CM CodesC00–D49C81-C96C81

ICD-10-CM C81.76
CMSSource: CMS FY 2026 ICD-10-CM dataset · Effective Oct 1, 2025 – Sep 30, 2026

C81.76 is a billable ICD-10-CM diagnosis code for other Hodgkin lymphoma, intrapelvic lymph nodes. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 820 through 825, 840 through 842. Coders also document this condition as Hodgkin's disease of intrapelvic lymph nodes. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Hodgkin lymphoma.

Code Identity

ICD-10-CM Code
C81.76
Billable Status
Yes — Valid for Submission
Code Describes
Other Hodgkin lymphoma, intrapelvic lymph nodes
Short Description
Other Hodgkin lymphoma, intrapelvic lymph nodes
Same as the full description in the CMS dataset.
Parent Code
Other Hodgkin lymphoma

Code Classification

ChapterC00–D49Neoplasms
SectionC81-C96Malignant neoplasms of lymphoid, hematopoietic and related tissue
CategoryC81Hodgkin lymphoma
This CodeC81.76Other Hodgkin lymphoma, intrapelvic lymph nodes

Approximate SynonymsGuidance

Alternate terms and clinical phrases that map to this code.

  • Hodgkin's disease of intrapelvic lymph nodes
  • Hodgkin's granuloma
  • Hodgkin's granuloma of intrapelvic lymph nodes
  • Hodgkin's sarcoma
  • Hodgkin's sarcoma of intra-abdominal lymph nodes
  • Hodgkin's sarcoma of intrapelvic lymph nodes

Clinical ClassificationClinical

AHRQ’s CCSR groups this code into broader clinical categories.

CCSR NEO057
Hodgkin lymphoma
Default principal diagnosis: inpatient Yes · outpatient Yes

Clinical InformationClinical

  • Hodgkin's Sarcoma

    an obsolete term referring to a hodgkin lymphoma that lacks inflammatory elements.

Patient EducationClinical

Hodgkin Lymphoma

Hodgkin lymphoma, also called Hodgkin disease, is a type of cancer that develops in the lymph system. Your lymph system is part of your immune system. It helps protect your body from infection and disease.

The full article covers:

  • What is Hodgkin lymphoma?
  • What causes Hodgkin lymphoma?
  • Who is more likely to develop Hodgkin lymphoma?
  • What are the symptoms of Hodgkin lymphoma?
  • How is Hodgkin lymphoma diagnosed?
  • What are the treatments for Hodgkin lymphoma?

Read the full article at MedlinePlus

Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.

Convert C81.76 to ICD-9-CMHistory

The closest ICD-9-CM equivalents under the General Equivalence Mappings.

ICD-9-CM
201.06 Hodgkins paragran pelvic
Approximate The match is approximate rather than exact.
ICD-9-CM
201.16 Hodgkins granulom pelvic
Approximate The match is approximate rather than exact.
ICD-9-CM
201.26 Hodgkins sarcoma pelvic
Approximate The match is approximate rather than exact.

Code HistoryHistory

FY 2016AddedAdded to the ICD-10-CM code setEffective October 1, 2015, the first year of ICD-10-CM.
FY 2017–2025No changes
FY 2026CurrentCurrent code set, no changesEffective October 1, 2025 through September 30, 2026.

Questions About C81.76Overview

Is C81.76 (Other Hodgkin lymphoma) a billable code?

Yes. This is a billable ICD-10-CM code, specific enough to report other Hodgkin lymphoma, intrapelvic lymph nodes on HIPAA-covered claims from October 1, 2025 through September 30, 2026.

What MS-DRG does C81.76 group to?

When other Hodgkin lymphoma, intrapelvic lymph nodes is the principal diagnosis on an inpatient stay, it groups to MS-DRG 820, 821, 822, 823, 824, 825, 840, 841, 842, with relative weights from 1.0104 to 5.8648 depending on complications. Higher weights mean higher Medicare reimbursement.

What is the ICD-9 equivalent of C81.76?

Under the General Equivalence Mappings, other Hodgkin lymphoma, intrapelvic lymph nodes converts to ICD-9-CM 201.06 (hodgkins paragran pelvic), 201.16 (hodgkins granulom pelvic), and 201.26 (hodgkins sarcoma pelvic). The mapping is approximate, so confirm the match fits the documentation.

Footnotes

[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:

  • The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
  • The condition places limitations on self-care, independent living, and social interactions.